Skip to main content

Syndax Pharmaceuticals Inc 10-Q for FY2025 Q2

Syndax Pharmaceuticals Inc (SNDX)

10-Q 2025-08-04 For: 2025-06-30
View Original
Added on April 09, 2026

About this 10-Q

Syndax Pharmaceuticals Inc filed this 10-Q on August 4, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).

Headline figures

Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$37.96M
up 984.5% from $3.5M a year earlier
Net loss
$71.85M
compared with a net loss of $68.06M a year earlier
Diluted EPS
-$0.83
compared with -$0.80 a year earlier